Renovaro Biosciences (RENB) - 2022 Q2 - Quarterly Report

U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number 001-38758 Enochian Biosciences Inc. (Exact name of registrant as specified in its charter) Delaware 45-2259340 (State or other jurisdiction of (I.R.S. Employer incorporation or organization) Identification Number) 2080 Century Park East, Suite 906 Los Angeles, CA (Address of principal executive offices) (Zip Code) 90067 For ...